Pafco Laboratories Profile
Key Indicators
- Authorised Capital ₹ 4.25 Cr
as on 05-01-2025
- Paid Up Capital ₹ 3.82 Cr
as on 05-01-2025
- Company Age 32 Year, 10 Months
- Last Filing with ROC 31 Mar 2020
- Open Charges ₹ 4,334.49 Cr
as on 05-01-2025
- Revenue 387.80%
(FY 2018)
- Profit -16645.27%
(FY 2018)
- Ebitda -2455.51%
(FY 2018)
- Net Worth -0.09%
(FY 2018)
- Total Assets 0.02%
(FY 2018)
About Pafco Laboratories
The Corporate was formerly known as Pafco Laboratories Pvt Limited. The Company is engaged in the Financial Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 4.25 Cr and a paid-up capital of Rs 3.82 Cr.
The company currently has active open charges totaling ₹4,334.49 Cr.
Ashish Mundhra, Deepak Vishwakarma, and Dharmendra Kumar serve as directors at the Company.
- CIN/LLPIN
U74220WB1992PLC054631
- Company No.
054631
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
05 Mar 1992
- Date of AGM
30 Dec 2020
- Date of Balance Sheet
31 Mar 2020
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Pafco Laboratories?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ashish Mundhra  | Director | 24-Mar-2022 | Current |
| Deepak Vishwakarma | Director | 15-Nov-2024 | Current |
| Dharmendra Kumar | Director | 15-Nov-2024 | Current |
Financial Performance of Pafco Laboratories.
Pafco Laboratories Limited, for the financial year ended 2018, experienced significant growth in revenue, with a 387.8% increase. The company also saw a substantial fall in profitability, with a 16645.27% decrease in profit. The company's net worth dipped by a decrease of 0.09%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pafco Laboratories?
In 2018, Pafco Laboratories had a promoter holding of 100.00%. The company had 2 Associate Companies. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 13 Feb 2017 | ₹15.11 Cr | Open |
Others Creation Date: 25 Apr 2016 | ₹1,396.34 Cr | Open |
Central Bank Of India Creation Date: 08 Mar 2016 | ₹122.68 Cr | Open |
How Many Employees Work at Pafco Laboratories?
Unlock and access historical data on people associated with Pafco Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pafco Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pafco Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
